Stock AYTU AYTU BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Aytu BioPharma, Inc.

Equities

AYTU

US0547548588

Delayed Nasdaq
Other stock markets
 03:04:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.64 USD -2.76% Intraday chart for Aytu BioPharma, Inc. -8.12% -7.04%
Feb. 14 Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024
Feb. 14 Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M MT

Chart calendar Aytu BioPharma, Inc.

d.oGJdv7KiEqmu6ZszTjRxaeVqlh2OkIWuUIyC9ObRkEs.yCY7i_zAdML9hPpHOloHJJdToSX40rbMffv1tsuV-wn0JjL7x-Ng09ah2g~eeff16440a34612762bd8c347168ae52

Upcoming events on Aytu BioPharma, Inc.

2024-05-12 Q3 2024 Earnings Release (Projected)
2024-09-24 Q4 2024 Earnings Release (Projected)
2024-11-13 Q1 2025 Earnings Release (Projected)
2025-02-11 Q2 2025 Earnings Release (Projected)

Past events on Aytu BioPharma, Inc.

2024-04-04 04:40 pm Emerging Growth Conference
2024-02-14 04:30 pm Q2 2024 Earnings Call
2024-02-14 04:05 pm Q2 2024 Earnings Release
2024-02-01 11:45 am Lytham Partners Investor Select Conference
2023-12-07 01:10 pm Emerging Growth Conference
2023-11-14 04:30 pm Q1 2024 Earnings Call
2023-11-14 04:05 pm Q1 2024 Earnings Release
2023-10-17 07:00 am Lytham Partners Fall Investor Conference
2023-10-04 01:00 pm LD Micro Main Event Conference
2023-09-27 04:30 pm Q4 2023 Earnings Call
2023-09-27 04:20 pm Q4 2023 Earnings Release
2023-06-21 03:00 pm Maxim Group Virtual Healthcare Conference
2023-05-18 12:00 pm Annual General Meeting
2023-05-11 04:30 pm Q3 2023 Earnings Call
2023-05-11 04:05 pm Q3 2023 Earnings Release
2023-02-21 05:00 pm Interim 2023 Earnings Call
2023-02-21 04:10 pm Interim 2023 Earnings Release
2023-01-31 09:00 am Lytham Partners virtual Investor Select Conference
2022-11-14 04:30 pm Q1 2023 Earnings Call
2022-11-14 04:05 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		7,32
7,38
-0.77%		27,6
24,0
15.01%		65,6
66,2
-0.78%		96,7
94,7
2.08%		107
104
2.91%
83,5

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-46,8
-21,8
-114.45%		-25,9
-68,3
62.15%		-4,94
-4,35
-13.64%
11,5

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-16,7
-0.98%		-20,9
-18,1
-15.89%		-58,9
-45,5
-29.38%		-112
-105
-6.1%		-12,3
-20,4
39.62%
-0,47

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-27,1
-16,9
-60.57%		-13,6
-17,1
20.18%		-58,0
-50,4
-15.25%		-110
-105
-5.38%		-17,1
-20,7
17.44%
-11,4

Net income
Million USD		Released
Forecast
Spread 		-27,1
-17,1
-59.06%		-13,6
-15,1
9.53%		-58,3
-50,4
-15.77%		-110
-105
-5.38%		-17,1
-20,7
17.44%
-12,2

EPS
USD		Released
Forecast
Spread 		-696
-430
-61.86%		-60,0
-44,0
-36.36%		-69,6
-56,8
-22.54%		-75,0
-71,5
-4.9%		-5,11
-6,16
17.05%
-2,23

Announcement Date26/09/1906/10/2027/09/2127/09/2227/09/23-

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		23,1
27,2
-14.98%		24,2
24,5
-1.23%		27,4
25,5
7.64%		27,7
24,3
13.81%		26,3
29,5
-10.92%		22,7
27,6
-17.48%		30,7
27,7
10.97%		22,1
27,7
-20.3%		22,9
21,7
5.47%
17,3


21,2

EBITDA
Million USD		Released
Forecast
Spread


-6,81
-7,50
9.2%		-4,86
-4,00
-21.45%


-2,02
4,60
-143.83%		-6,36
1,20
-630.33%		4,65
0,09
4948.91%		0,44
1,65
-73.52%		5,08
0,35
1352.29%
0,50


3,73

EBIT
Million USD		Released
Forecast
Spread 		-11,3
-14,4
21.57%		-54,7
-11,3
-385.82%		-17,9
-11,5
-55.77%		-1,65
-9,00
81.63%		-4,19
-1,70
-146.65%		-8,56
-2,20
-289%		2,81
-2,68
204.81%		-1,50
1,05
-243.92%		2,36
-0,09
2726.67%
-2,26


0,94

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-11,6
-14,9
22.48%		-53,1
-11,9
-347.87%		-17,7
-12,1
-46.29%		-2,88
-9,40
69.35%		-6,69
-2,00
-234.65%		-7,20
-2,55
-182.35%		-2,46
-3,88
36.68%		-8,12
-0,24
-3340.68%		0,61
-1,37
144.35%
-3,54


-0,35

Net income
Million USD		Released
Forecast
Spread 		-11,5
-14,9
22.5%		-53,1
-11,9
-347.87%		-17,7
-12,1
-46.29%		-2,88
-9,40
69.35%		-6,69
-2,10
-218.71%		-7,20
-2,55
-182.35%		-2,46
-3,88
36.68%		-8,12
-0,24
-3340.68%		-0,22
-1,37
83.95%
-3,54


-0,35

EPS
USD		Released
Forecast
Spread 		-8,80
-11,6
24.14%		-35,8
-8,20
-336.59%		-7,00
-7,40
5.41%		-1,20
-3,60
66.67%		-2,15
-0,70
-207.14%		-1,93
-0,72
-169.93%		-0,59
-0,95
37.89%		-1,48
-0,04
-3600%		-0,04
-0,25
84%
-0,64


-0,06

Announcement Date14/02/2216/05/2227/09/2214/11/2221/02/2311/05/2327/09/2314/11/2314/02/24--

Upcoming sector events for Aytu BioPharma, Inc.

2024-04-24 HIKMA PHARMACEUTICALS PLC: Q1 2024 Sales and Revenue Release - Trading Update
2024-04-24 IPSEN: Q1 2024 Sales and Revenue Release
2024-04-24 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q4 2023 Earnings Release
2024-04-24 CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD: Q1 2024 Earnings Release
2024-04-24 HUNAN JIUDIAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-24 ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-24 OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 LAURUS LABS LIMITED: Q4 2024 Earnings Release
2024-04-24 PT KALBE FARMA TBK.: Q1 2024 Earnings Release (Projected)
2024-04-24 GLENMARK LIFE SCIENCES LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Aytu BioPharma, Inc.

Today 01:00 am ROCHE HOLDING AG: Q1 2024 Sales and Revenue Release
Today 08:05 pm NEUREN PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report
Today KINGCHEM (LIAONING) LIFE SCIENCE CO., LTD.: Q1 2024 Earnings Release
Today HANGZHOU MINSHENG HEALTHCARE CO., LTD.: Q4 2023 Earnings Release
Today NEWLAND PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today BEIJING FOYOU PHARMA CO.,LTD: Q1 2024 Earnings Release
Today PHARMABLOCK SCIENCES (NANJING), INC.: Q1 2024 Earnings Release
Today BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release (Projected)
Today GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q1 2024 Earnings Release
Today BEIJING SL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AYTU Stock
  4. Calendar Aytu BioPharma, Inc.